Crosslinking of membrane immunoglobulin (mIg) receptors by anti-Ig causes growth inhibition and subsequent cell death due to apoptosis in a murine B-cell lymphoma model. The earliest signal transduction via mIg has recently been shown to be dependent on the activation of one or more protein tyrosine kinases (PTKs). In this study, we utilized the CH31 lymphoma, which is extremely sensitive to growth inhibition by anti-Ig, to examine the role of PTKs in cell cycle arrest. This cell line expresses multiple PTKs, whose activities are stimulated by crosslinking mIg. To determine whether PTK activity is essential for the inhibition of cell growth, we exposed CH31 cells to antisense oligodeoxynucleotides for the blk PTK prior to the growth inhibition assay. We found that exposure of CH31 cells to blk antisense effectively prevented anti-,u-chain-mediated growth inhibition and subsequent apoptosis. Corresponding blk sense or antisense oligonucleotides for other PTKs had no protective effect against anti-p. Moreover, antisense blk oligonudeotides had no effect on transforming growth factor 3-mediated growth arrest and apoptosis. Further experiments showed significantly reduced endogenous p55b"k in blk antisense-treated cells. In addition, anti-p stimulation of antisense-treated cells failed to induce any detectable increase in kinase activity of p55bDk, a result suggestIng the uncoupling of blk proteins from normal signal pathways that are essential for growth inhibition. These results implicate a role ofblk kinase in anti-p-mediated pathway to cell cyde arrest. We and others have recently found differential expression and activation patterns of blk, lck, lyn, and fyn kinases in a panel of immature B-lymphoma cells, which represent different subsets or stages of B-cell maturation and vary in their response to crosslinking of mIg by anti-Ig in terms of growth inhibition (9, 10). A close association was found between level of activatable blk kinase and the inhibitory phenotype, in that blk protein was present in all lymphomas that are inhibited by anti-A (9). These observations led us to investigate whether blk kinase is engaged in this inhibitory signaling pathway. Since antisense strategy has been successfully utilized to block the function of a number of gene products (11-13), we decided to use blk antisense oligonucleotides to explore the functional role of blk kinase in anti-,u-chainmediated growth inhibition. In the present study, we demonstrate that pretreatment of CH31 B-lymphoma cells with blk antisense could effectively prevent anti-,u-induced growth inhibition and subsequent apoptosis. Based on these studies, we suggest that endogenous expression of blk gene product is required for mediation of inhibitory signaling by crosslinking of mIg.
whether PTK activity is essential for the inhibition of cell growth, we exposed CH31 cells to antisense oligodeoxynucleotides for the blk PTK prior to the growth inhibition assay. We found that exposure of CH31 cells to blk antisense effectively prevented anti-,u-chain-mediated growth inhibition and subsequent apoptosis. Corresponding blk sense or antisense oligonucleotides for other PTKs had no protective effect against anti-p. Moreover, antisense blk oligonudeotides had no effect on transforming growth factor 3-mediated growth arrest and apoptosis. Further experiments showed significantly reduced endogenous p55b"k in blk antisense-treated cells. In addition, anti-p stimulation of antisense-treated cells failed to induce any detectable increase in kinase activity of p55bDk, a result suggestIng the uncoupling of blk proteins from normal signal pathways that are essential for growth inhibition. These results implicate a role ofblk kinase in anti-p-mediated pathway to cell cyde arrest.
The src family of non-receptor protein tyrosine kinases (PTKs) is fundamentally important in controlling cellular growth and differentiation. Currently, at least eight members of this gene family, including blk, fgr, fyn, hck, Ick, lyn, src, and yes, have been identified (1) . These PTKs are expressed in a variety of cell types and participate in ligand-mediated signal transduction events. In B-lineage cells, multiple PTKs have been shown to be noncovalently coupled to membrane Ig-receptor complex, including p55blk, p59fyf, p53/56'Yn, and p56lck (2-4). More importantly, crosslinking of membrane immunoglobulin (mIg) by anti-Ig induces activation of these PTKs (2-4). One of the immediate consequences of PTK activation is tyrosine phosphorylation of several important intermediate effectors, such as phospholipase C-y (5, 6), phosphatidylinositol 3-kinase (7), and GTPase activating protein (8), through which PTKs accomplish their role in signal transduction. However, the functional meaning of multiple activation of PTKs by crosslinking mlg remains unclear. In the immune response, ligation ofthe mlg complex must be capable ofeliciting stimulatory signaling, which leads to cell growth and differentiation, or an inhibitory response, which causes anergy and tolerance. The developmentally
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We and others have recently found differential expression and activation patterns of blk, lck, lyn, and fyn kinases in a panel of immature B-lymphoma cells, which represent different subsets or stages of B-cell maturation and vary in their response to crosslinking of mIg by anti-Ig in terms of growth inhibition (9, 10). A close association was found between level of activatable blk kinase and the inhibitory phenotype, in that blk protein was present in all lymphomas that are inhibited by anti-A (9). These observations led us to investigate whether blk kinase is engaged in this inhibitory signaling pathway. Since antisense strategy has been successfully utilized to block the function of a number of gene products (11-13), we decided to use blk antisense oligonucleotides to explore the functional role of blk kinase in anti-,u-chainmediated growth inhibition. In the present study, we demonstrate that pretreatment of CH31 B-lymphoma cells with blk antisense could effectively prevent anti-,u-induced growth inhibition and subsequent apoptosis. Based on these studies, we suggest that endogenous expression of blk gene product is required for mediation of inhibitory signaling by crosslinking of mIg.
MATERIALS AND METHODS
Lymphoma Cell Line and Growth Inhibition. The origin and properties of the murine B-cell lymphoma CH31 have been noted previously (14) (15) (16) . These cells were maintained in RPMI 1640 complete medium supplemented with 5% heatinactivated fetal bovine serum, 50 mM mercaptoethanol, and antibiotics (100 units of penicillin per ml, 100 pg of streptomycin per ml). Growth inhibition was determined by [3H]thymidine incorporation in a standard protocol. Briefly, cells (104 per well) were plated in flat-bottom 96-well microculture plates and incubated in the presence of indicated amount of affinity-purified rabbit anti-,u for 20 hr at 37°C with 7% CO2. Cells were then pulsed with 1 ,Ci of [3H]thymidine (1 Ci = 37 GBq) for another 4 hr before harvesting onto glass fiber filters on a Micromate 1% harvester; the radioactivity was then quantitated using a Matrix 96 direct 3counter (Packard) and converted to average cpm. Data are presented as percent control (no anti-,); standard errors were always <10% and are not indicated.
Antibodies. Rabbit anti-blk antibody was generated as described (16). Briefly, rabbits were immunized with overlapping 26-mers corresponding to residues 7-54 ofthe murine blk sequence. Rabbit antibodies to lyn and fyn peptides were [-"S]Methionine Labeling and Immunoprecipitation. Lymphoma cells were washed and resuspended in methioninefree medium at a concentration of 2 x 107 per ml. Cells were metabolically labeled with 500 pCi of [35S]methionine per ml (800 Ci/mmol; NEN) for 3 hr at 37°C. The labeled cells were washed and then solubilized in lysing buffer. Lysates were precleared by a sequential incubation with (i) protein A-Sepharose plus 25 ,ug of normal rabbit IgG, (ii) Sepharose beads alone, and (iii) protein A-Sepharose, with rotation at 4°C for 2 hr for each step. The precleared lysates were immunoprecipitated with affinity-purified rabbit anti-blk antibody coupled to protein A-Sepharose beads. The washed precipitates were eluted in SDS sample buffer and boiled for 2 min prior to SDS/PAGE gel (8%) analysis.
Anti-Phosphotyrosine Blotting. Lymphoma cells (2 x 106 per ml) were prewarmed at 37°C for 10 min and stimulated with 10 pug of affinity-purified goat (Fab')2 anti-,u per ml (Jackson ImmunoResearch) or indicated doses of transforming growth factor P (TGF-P3) at 37°C for 5 min. After treatment, cells were pelleted and solubilized in 100 pl of lysing buffer (1% Triton X-100/25 mM Tris HCl, pH 7.6/150 mM NaCl/l mM phenylmethylsulfonyl fluoride/lO ug of leupeptin per ml/10 pug of aprotinin per ml/i mM EDTA/50 mM NaF/1 mM orthovanadate) on ice for 20 min. Detergentinsoluble materials were removed by centrifugation at 10,000 x g for 20 min at 4°C. Protein samples were denatured in SDS/PAGE sample buffer and separated by electrophoresis in 8% SDS/polyacrylamide gel. The resolved proteins were transferred onto nitrocellulose (Bio-Rad) in a buffer containing 25 mM Tris, 192 mM glycine, and 20% methanol (pH 9.0) at 20 V overnight. Prestained protein standards were included to indicate the molecular weight range and to verify transfer. After blocking in 1% bovine serum albumin in TBS-T (50 mM Tris/200 mM NaCl, pH 7.5/0.05% Tween 20), the nitrocellulose blots were incubated with a murine monoclonal antiphosphotyrosine antibody (PY2O), followed by an incubation with horseradish peroxidase-linked goat-anti-mouse IgG (H+L) at a dilution of 1:2000. The proteins that reacted were visualized by enhanced chemiluminescence (Amersham).
Immune Complex Kinase Activity Assay. Immunoprecipitation was performed as described above. After the final wash with kinase assay buffer (20 mM Hepes, pH 7.5/100 mM NaCl/5 mM MnCl2/5 mM MgCl2), the immunoprecipitates were resuspended in 50 y1 of the same buffer, and the autophosphorylation of PTKs was initiated by adding 1 AM unlabeled ATP and 10-20 ,uCi of [y-32P]ATP (4500 Ci/mmol; Amersham). The reaction mixture was incubated at room temperature for 15 min, and the reaction was then stopped with lysis buffer containing 20 mM EDTA. The beads that reacted were washed three times in lysis buffer and eluted proteins were separated by SDS/PAGE in 8% gels. Autoradiography was then performed by exposure to Kodak XAP film with intensifying screen at -80°C.
RESULTS AND DISCUSSION
Multiple Expression and Activation of PTKs in CH31 Lymphoma Cells. One of the earliest biochemical events in signal transduction through B-cell antigen receptors is tyrosine phosphorylation/activation of protein tyrosine kinases. Currently, four of the eight known src-like PTKs are shown to be coupled with mlg receptor complexes in B-lineage cells. Therefore, we sought to examine the activation of those PTKs in CH31 lymphoma cells. We used PTK-specific antibodies for immunoprecipitation and then detected these PTKs by radiolabeling with [-32P ]ATP based on the ability ofPTKs to autophosphorylate during an in vitro kinase assay. As shown in Fig. 1 , unstimulated CH31 cells expressed constitutively detectable kinase activities of p55blk, p53/ 56'yn, and p56lck PTKs; there was no detectable p59fyn kinase activity in these lymphoma cells. The lack of p59fYI kinase activity was not due to the failure of autophosphorylation because p59fYn protein also was not present in CH31 cells by direct immunoblotting (9). In addition, crosslinking of mIgM receptor induced a 2-fold increase ofp55b"k activity, a 2-3-fold increase of p53/56'yn kinase, and a 2-fold increase of p561ck activity as determined by densitometer scanning (LKB UltroScan XL), a result suggesting activation of these PTKs by anti-,u stimulation.
blk Antisense Prevents Anti-p-Induced Growth Inhibition. We have previously shown that expression and activation of p55blk kinase are closely correlated with the anti-pu inhibitory phenotype in a panel of B-cell lymphoma cell lines (9). To determine the functional significance of p55bIk kinase in anti-,-induced growth arrest, the most sensitive cell line, CH31, was chosen for efforts to block the expression ofp55bIk kinase by culture with blk antisense. In initial control experiments, we examined the toxicity, specificity, and modulation of membrane IgM receptor expression by these oligonucleotides in logarithmic-phase CH31 lymphoma cells. We found that in the presence of up to 10 pM blk antisense or sense oligonucleotides, CH31 cells grow as well as control cells, as measured by [3H]thymidine incorporation (unpublished) . An exception was that nonsense oligonucleotides caused a 20-30% reduction of [3H]thymidine uptake when used at concentrations >5 p.M in a 24-hr assay. Therefore, in most of our experiments, 5 p.M of each oligonucleotide was used as a standard concentration, except where noted. We also measured CH31 cells for the expression of membrane IgM receptors after a 48-hr incubation in the presence of blk antisense or sense oligonucleotides and did not observe any significant shift in the IgM density by flow cytometry analysis (ref. 9 and data not shown).
We then examined the effect of blk antisense on anti-p.-mediated growth arrest. Exponentially growing CH31 cells were exposed to 5 p.M blk antisense, sense, or nonsense for 48 hr and then assayed for growth inhibition by anti-p. treatment. As shown in Fig. 2a , untreated CH31 cells were growth arrested in the presence of anti-pu. However, cells pretreated with blk antisense exhibited significant protection against growth arrest by anti-IL; blk sense or nonsense had no such protective effect. Fig. 2b shows a typical anti-p. titration with three different doses of blk antisense. These results show that as little as 1 p.M blk antisense reversed growth inhibition from approximately 4% to 56% of control growth with 0.8 p.g of anti-,u per ml.
In a separate experiment to establish the half-life of blk kinase, we determined the time dependence of the effect of blk antisense oligonucleotides. CH31 cells were exposed to 5 p.M blk antisense or sense oligonucleotides for various times (6-48 hr) and assayed for growth inhibition by anti-p. in the continued presence of the respective oligonucleotides. Significant protection began between 12 and 24 hr, but longer 8 (1-1000 ng/ml) at 37°C for 5 min. Control cells were left unstimulated. Cell pellets were lysed in 1% Triton X-100. The protein samples were fractionated by SDS/PAGE (8% gel) and transferred onto nitrocellulose filters. Tyrosine-containing proteins were probed with monoclonal antibody PY20. Lane 1, control; lane 2, anti-p.-stimulated cells (10 p,g/ml); lanes 3-6, TGF-f-stimulated cells (1, 10, 100, and 1000 ng/ml). Prestained molecular standards are indicated in kDa. (Fig.  2c) . Again, blk sense did not significantly affect growth inhibition by anti-,u at any time point.
As shown above, CH31 cells also contained p53/56'Yn and p561ck kinases whose activities were simultaneously stimulated by crosslinking of mIgM. To determine whether these kinases were involved in the inhibitory signaling pathway, we incubated CH31 cells with blk, fyn, lyn, or Ick antisense oligonucleotides for 48 hr and examined these cells for growth inhibition. At similar molar concentrations (5 ,uM), blk antisense effectively prevented growth inhibition, butfyn, lyn, or Ick antisense-treated cells were not protected against anti-IL (Fig. 2d) . Thus, it is most likely that p53/56kyn and p561ck kinases were not required for anti-,u-mediated growth arrest, although both of these PTKs were activated by anti-,u stimulation. This result suggests that each PTK may participate in a separate signaling pathway. Since neither the blk sense nor the unrelated antisense oligonucleotides had any consistent protective effect on growth inhibition, we concluded that the prevention of growth inhibition was due to a specific biological effect of blk antisense oligonucleotides.
blk Antisense Does Not Alter TGF-1-Mediated Growth Inhibition. Previously, we reported that the growth of CH31 cells could also be inhibited by TGF-,B (21). Recent data suggest that TGF-j exerts its inhibitory effect through a protein kinase C-dependent pathway (23). As a specificity control for these experiments, we compared the effect of blk antisense on anti-,-versus TGF-3-mediated growth inhibition in CH31 cells. As expected, treatment with blk antisense was able to provide protection against the inhibitory effect by anti-,u (Fig. 3a) but it did not significantly alter TGF-3-mediatcd growth arrest since the cells loaded with blk antisense remained susceptible to TGF-P (Fig. 3b) . To further confirm the independence of TGF-j3 signaling of tyrosine kinase activity, we conducted anti-phosphotyrosine analysis in anti-,u-or TGF-,B3stimulated cells. As demonstrated in Fig.   3c , the stimulation of CH31 cells with anti-.u induced tyrosine phosphorylation of a number of intracellular substrate proteins, with major molecular sizes of approximately 35, 54-56, 63, 66, 69, 125, 130, and 150 kDa, whereas TGF-(3 failed to stimulate any significantly increased tyrosine phosphorylation of those intracellular substrates, even at a dose of 1 pAg/ml, which is 100 times higher than that required for complete growth inhibition in CH31 cells (Fig. 3b) . This result suggests that TGF-,(mediated inhibitory signaling pathway is not dependent on protein tyrosine kinase activity, including the blk kinase.
blk Antisense Prevents Anti-#-Mediated Apoptosis. It has been established that early G1 is a critical phase of the cell cycle during which anti-IL initiates signals for growth arrest in Fig. 5a , the immunoprecipitates prepared from control cells displayed a predominant protein band about 55 kDa in size, corresponding to blk protein (lane 2). When examined in blk antisense-treated CH31 cells, the density of this protein band was decreased by S50% (lane 4) compared to untreated (lane 2) or blk sense-treated cells (lane 6) . This blockade of protein translation was blk-specific since the density of ,u chain and light chain bands of IgM was identical in untreated, blk antisense, or sense-treated cells (Fig. Sb) . Our data, therefore, indicate that a quantitative reduction in available blk protein can have profound effects on its biologic function in signal transduction.
To further test whether the p55blk kinase activity was affected in antisense-treated cells, anti-blk immune complexes were prepared from cells treated with antisense, sense, or control oligonucleotides and subjected to an in vitro kinase assay to allow for kinase autophosphorylation. As shown in Fig. 6 , SDS/PAGE analysis of these immune complexes revealed a 2-to 3-fold decrease of radiolabeled p55blk protein in antisense-treated cells (lane 3) when compared with that seen in control (lane 1) or sense-treated cells (lane 5). This observation is consistent with our immunoprecipitation data (Fig. Sa) . The most significant finding is that stimulation of antisense-treated cells with anti-,u did not induce any notable increase in relative kinase activity of p55blk (Fig. 6, lane 4) , whereas significant and comparable increases in the activity of p55blk kinase were seen in control or sense-treated cells by crosslinking of membrane IgM (Fig.  6, lanes 2 and 6) . The failure to elicit increased kinase activity can be explained by uncoupling of p55blk from membrane Ig receptor complexes due to insufficient expression of p55blk proteins in antisense-treated cells, as it has been suggested that PTKs compete for binding to Ig receptor complexes depending on their relative abundance (25).
In summary, our results implicate the blk PTK as a critical component in the signaling for growth arrest and apoptosis in the CH31 lymphoma. Whether this result can be generalized to other murine B-cell lines is yet to be determined.
